Method and apparatus for measurement of neural response

US10278600B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10278600-B2
Application numberUS-201615184787-A
CountryUS
Kind codeB2
Filing dateJun 16, 2016
Priority dateMay 13, 2011
Publication dateMay 7, 2019
Grant dateMay 7, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method for measuring a neural response to a stimulus. Measurement circuitry is settled prior to a stimulus, by connecting a sense electrode to the measurement circuitry to allow the measurement circuitry to settle towards a bio-electrically defined steady state. Charge is recovered on stimulus electrodes by short circuiting the stimulus electrodes to each other. An electrical stimulus is then applied from the stimulus electrodes to neural tissue, while keeping the sense electrode disconnected from the measurement circuitry. After the stimulus, a delay is imposed during which the stimulus electrodes are open circuited and the sense electrode is disconnected from the measurement circuitry and from the stimulus electrodes. After the delay, a neural response signal present at the sense electrode is measured by connecting the sense electrode to the measurement circuitry.

First claim

Opening claim text (preview).

The invention claimed is: 1. An implantable device for measuring a neural response to a stimulus, the device comprising: a plurality of electrodes including at least one nominal stimulus electrode and at least one nominal sense electrode; a stimulus source for providing a stimulus to be delivered from the one or more stimulus electrodes to neural tissue; measurement circuitry for amplifying a neural signal sensed at the one or more sense electrodes; and a control unit configured to control application of a stimulus to the neural tissue and measurement of an evoked neural response, the control unit configured to settle the measurement circuitry prior to a stimulus by connecting the at least one sense electrode to the measurement circuitry to allow the measurement circuitry to settle towards a bio-electrically defined steady state, the control unit further configured to recover charge on the stimulus electrodes by short circuiting the stimulus electrodes to each other, the control unit further configured to cause the stimulus source to apply an electrical stimulus from the stimulus electrodes to neural tissue while keeping the at least one sense electrode disconnected from the measurement circuitry, the control unit further configured to impose a delay during which the stimulus electrodes are open circuited and the sense electrode is disconnected from the measurement circuitry and from the stimulus electrodes, and the control unit further configured to measure a neural response signal present at the sense electrode by connecting the at least one sense electrode to the measurement circuitry after the delay. 2. The device of claim 1 , wherein the control unit is further configured to open circuit the at least one sense electrode during the post-stimulus delay so the at least one sense electrode is disconnected from all other electrodes of the array, to prevent charge transfer to the at least one sense electrode from other non-stimulus electrodes. 3. The device of claim 1 , wherein the control unit is further configured to undertake repeated measurement cycles and to allow a measurement amplifier to accumulate a bio-electrically defined steady state bias point over multiple cycles without re-setting the bias point each cycle. 4. The device of claim 1 , wherein the control unit is further configured to cause the settle period to be sufficiently long to permit the electrodes and the measurement circuitry to reach an equilibrium, as permitted by a stimulus rate. 5. The device of claim 1 , wherein the control unit is further configured to provide for the delay to be in the range of substantially zero to 1 ms. 6. The device of claim 5 , wherein the control unit is further configured to provide for the delay to be in the range of substantially 50 to 200 μs. 7. The device of claim 1 , wherein the control unit is further configured to provide for the delay to take a value which ensures a measurement amplifier is not saturated and therefore performs linearly at all times when connected without experiencing clipping. 8. The device of claim 7 , further comprising a feedback loop configured to seek a suitable minimum delay which avoids amplifier saturation for a given stimulus. 9. The device of claim 1 , configured to pass the signal from the at least one sense electrode to a sample-and-hold circuit at the input of the measurement circuitry. 10. The device of claim 1 , further comprising a buffer or follower amplifier connected between the at least one sense electrode and a measurement amplifier, so that the high reverse impedance of the buffer effectively prevents switching transients from being conveyed to the sense electrode. 11. The device of claim 1 , wherein a buffer amplifier is configured to give current gain to drive a storage capacitor of a sample and hold circuit. 12. The device of claim 10 , further comprising a series capacitor interposed between the at least one sense electrode and the buffer to avoid DC transfer with the tissue. 13. The device of claim 1 , further comprising an electrode array, and wherein the control unit is further configured to select the at least one stimulus electrode and the at least one sense electrode from electrodes of the electrode array. 14. The device of claim 13 , further comprising a respective measurement amplifier associated with each electrode of the electrode array, configured so as to avoid the need to switch the at least one sense electrode to a shared measurement amplifier. 15. The device of claim 1 , wherein the control unit is further configured to disconnect the at least one sense electrode from the measurement circuitry, while recovering charge by short circuiting at least two of the at least one stimulus electrodes together. 16. The device of claim 15 , wherein the control unit is configured to disconnect the at least one sense electrode from the measurement circuitry by setting a sample-and-hold circuit to “hold”. 17. The device of claim 1 , wherein the control unit is further configured to obtain an averaged CAP measurement by (i) delivering a first stimulus of a first polarity, and obtaining a first measurement of a CAP evoked by the first stimulus; (ii) delivering a second stimulus of a second polarity opposite to the first polarity, and obtaining a second measurement of a CAP evoked by the second stimulus; and (iii) taking an average of the first measurement and the second measurement to obtain an averaged measurement. 18. The device of claim 17 , wherein the control unit is further configured to obtain a curve of the averaged measurement vs. stimulus amplitude in order to obtain information regarding the recruitment effected by each stimulus. 19. The device of claim 18 , wherein the control unit is further configured to use the recruitment information for feedback control of a future stimulus. 20. The device of claim 1 , wherein the control unit is further configured to control drug delivery by feedback based on CAP measurements. 21. The device of claim 1 , wherein the at least one sense electrode is within 3 cm of the at least one stimulus electrode. 22. The device of claim 1 , wherein the stimulus source is configured to deliver a bi-phasic pulse, and wherein the at least one stimulus electrode is configured with no capacitors so as to permit a stimulus electrode current to be interrupted or forced to zero.

Assignees

Inventors

Classifications

  • using physiological parameters · CPC title

  • specified by the stimulation parameters · CPC title

  • for synchronizing or triggering a physiological measurement or image acquisition with a physiological event or waveform, e.g. an ECG signal · CPC title

  • Details of circuitry or electric components · CPC title

  • using feedback of body parameters, e.g. blood-sugar, pressure (measurement of body parameters A61B5/00) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10278600B2 cover?
A method for measuring a neural response to a stimulus. Measurement circuitry is settled prior to a stimulus, by connecting a sense electrode to the measurement circuitry to allow the measurement circuitry to settle towards a bio-electrically defined steady state. Charge is recovered on stimulus electrodes by short circuiting the stimulus electrodes to each other. An electrical stimulus is then…
Who is the assignee on this patent?
Saluda Medical Pty Ltd
What technology area does this patent fall under?
Primary CPC classification A61N1/36146. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).